UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000028749 |
|---|---|
| Receipt number | R000032844 |
| Scientific Title | A phase II study of perioperative capecitabine plus Oxaliplatin(CapeOx) therapy for advanced gastric cancer with multiple lymph node metastases (OGSG 1701) |
| Date of disclosure of the study information | 2017/09/01 |
| Last modified on | 2025/08/27 20:08:30 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/08/20 01:44:47 | ||
| 2 | Update | 2017/08/20 02:10:18 | Key exclusion criteria |
|
| 3 | Update | 2017/08/20 02:28:41 | Address |
|
| 4 | Update | 2017/08/21 22:23:09 | Email Name of person sending information |
|
| 5 | Update | 2017/08/22 22:00:17 | Public title Acronym |
|
| 6 | Update | 2017/08/22 22:03:47 | Narrative objectives1 Narrative objectives1 Primary outcomes Key secondary outcomes |
|
| 7 | Update | 2017/08/22 22:19:49 | Division name Organization |
|
| 8 | Update | 2017/09/29 01:17:02 | Recruitment status |
|
| 9 | Update | 2018/02/20 23:49:24 | Email |
|
| 10 | Update | 2018/08/01 06:44:57 | UMIN ID1 |
|
| 11 | Update | 2018/08/22 21:37:36 | Institutions |
|
| 12 | Update | 2018/08/22 21:38:34 | Anticipated trial start date |
|
| 13 | Update | 2019/02/20 22:58:49 | Institutions |
|
| 14 | Update | 2020/01/05 21:31:47 | Date of IRB |
|
| 15 | Update | 2022/08/28 17:55:51 | Recruitment status Last follow-up date |
|
| 16 | Update | 2022/08/28 17:59:57 | Number of participants that the trial has enrolled |
|
| 17 | Update | 2025/05/25 22:48:30 | URL releasing protocol Publication of results Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 18 | Update | 2025/08/27 20:08:30 | Recruitment status |
